Now in its 14th year, Frontiers in Cancer Immunotherapy brings together leading researchers, clinicians, and industry innovators to explore the next generation of therapies that are transforming cancer treatment.
The field of immuno-oncology has achieved remarkable breakthroughs over the past decade. Yet, many challenges remain—from understanding the biology of resistant tumor types to identifying novel therapeutic targets and strategies. This year’s symposium will showcase cutting-edge research and highlight promising approaches in areas such as immunometabolism, resistance to immunotherapy, in vivo immune engineering, emerging therapeutic modalities, aging and immune dysfunction, cell therapy for AML, and more.
In addition to keynote presentations and plenary talks, the program features industry updates, short talks selected from abstracts, and a panel discussion on the role of survivor partnerships in propelling cancer research forward. Ample networking opportunities will give participants the chance to connect with peers, collaborators, and leaders shaping the future of cancer immunotherapy.
Join us in New York City to share knowledge, foster new collaborations, and be part of the conversation driving the next breakthroughs in cancer treatment
